These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 25359211

  • 1. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
    Wang SS, Gu YF, Wolff N, Stefanius K, Christie A, Dey A, Hammer RE, Xie XJ, Rakheja D, Pedrosa I, Carroll T, McKay RM, Kapur P, Brugarolas J.
    Proc Natl Acad Sci U S A; 2014 Nov 18; 111(46):16538-43. PubMed ID: 25359211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade.
    Gu YF, Cohn S, Christie A, McKenzie T, Wolff N, Do QN, Madhuranthakam AJ, Pedrosa I, Wang T, Dey A, Busslinger M, Xie XJ, Hammer RE, McKay RM, Kapur P, Brugarolas J.
    Cancer Discov; 2017 Aug 18; 7(8):900-917. PubMed ID: 28473526
    [Abstract] [Full Text] [Related]

  • 4. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
    Togo Y, Yoshikawa Y, Suzuki T, Nakano Y, Kanematsu A, Zozumi M, Nojima M, Hirota S, Yamamoto S, Hashimoto-Tamaoki T.
    Int J Oncol; 2016 Apr 18; 48(4):1571-80. PubMed ID: 26891804
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.
    Am J Pathol; 1996 Dec 18; 149(6):2089-94. PubMed ID: 8952541
    [Abstract] [Full Text] [Related]

  • 7. A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.
    Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J.
    Mol Cancer Res; 2013 Sep 18; 11(9):1061-1071. PubMed ID: 23709298
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer.
    Liao L, Testa JR, Yang H.
    Cancer Genet; 2015 May 18; 208(5):206-14. PubMed ID: 25873528
    [Abstract] [Full Text] [Related]

  • 10. Bap1 and Pbrm1: Determinants of Tumor Grade and mTOR Activation in VHL-Deficient Mouse Models of Renal Cell Carcinoma.
    Leung JY, Kim WY.
    Cancer Discov; 2017 Aug 18; 7(8):802-804. PubMed ID: 28765116
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.
    Cancer Res; 2001 Oct 01; 61(19):7277-81. PubMed ID: 11585766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths.
    Poehlman WL, Hsieh JJ, Feltus FA.
    Sci Rep; 2019 Feb 27; 9(1):2899. PubMed ID: 30814637
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition.
    Vlachostergios PJ, Papathanassiou M, Anagnostou M, Thodou E, Tamposis I, Mitrakas L, Zachos I, Koukoulis GK, Samara M, Tzortzis V.
    F1000Res; 2023 Feb 27; 12():918. PubMed ID: 38933491
    [Abstract] [Full Text] [Related]

  • 16. Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.
    Hamano K, Esumi M, Igarashi H, Chino K, Mochida J, ISHIDA And H, Okada K.
    J Urol; 2002 Feb 27; 167(2 Pt 1):713-7. PubMed ID: 11792959
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M, Lott ST, Wong P, El-Naggar A, Tucker S, Killary AM.
    Cancer Res; 1999 May 01; 59(9):2182-9. PubMed ID: 10232606
    [Abstract] [Full Text] [Related]

  • 19. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.
    Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, Hricak H, Motzer R, Hsieh JJ, Akin O.
    Radiology; 2014 Feb 01; 270(2):464-71. PubMed ID: 24029645
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.